27291828|t|Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse.
27291828|a|Histaminergic H3 receptors (H3R) antagonists enhance cognition in preclinical models and modulate neurotransmission, in particular acetylcholine (ACh) release in the cortex and hippocampus, two brain areas involved in memory processing. The cognitive deficits seen in aging and Alzheimer's disease have been associated with brain cholinergic deficits. Donepezil is one of the acetylcholinesterase (AChE) inhibitor approved for use across the full spectrum of these cognitive disorders. We addressed the question if H3R antagonists and donepezil require an intact histamine neuronal system to exert their procognitive effects. The effect of the H3R antagonist ABT-239 and donepezil were evaluated in the object recognition test (ORT), and on the level of glycogen synthase kinase 3 beta (GSK-3beta) phosphorylation in normal and histamine-depleted mice. Systemic administration of ABT-239 or donepezil ameliorated the cognitive performance in the ORT. However, these compounds were ineffective in either genetically (histidine decarboxylase knock-out, HDC-KO) or pharmacologically, by means of intracerebroventricular (i.c.v.) injections of the HDC irreversible inhibitor a-fluoromethylhistidine (a-FMHis), histamine-deficient mice. Western blot analysis revealed that ABT-239 or donepezil systemic treatments increased GSK-3beta phosphorylation in cortical and hippocampal homogenates of normal, but not of histamine-depleted mice. Furthermore, administration of the PI3K inhibitor LY294002 that blocks GSK-3beta phosphorylation, prevented the procognitive effects of both drugs in normal mice. Our results indicate that both donepezil and ABT-239 require the integrity of the brain histaminergic system to exert their procognitive effects and strongly suggest that impairments of PI3K/AKT/GSK-3beta intracellular pathway activation is responsible for the inefficacy of both drugs in histamine-deficient animals.
27291828	0	9	Donepezil	Chemical	MESH:D000077265
27291828	52	59	ABT-239	Chemical	MESH:C496397
27291828	63	84	histamine H3 receptor	Gene	99296
27291828	144	153	histamine	Chemical	MESH:D006632
27291828	214	219	mouse	Species	10090
27291828	221	247	Histaminergic H3 receptors	Chemical	-
27291828	352	365	acetylcholine	Chemical	MESH:D000109
27291828	367	370	ACh	Chemical	MESH:D000109
27291828	462	480	cognitive deficits	Disease	MESH:D003072
27291828	499	518	Alzheimer's disease	Disease	MESH:D000544
27291828	551	571	cholinergic deficits	Disease	MESH:C535672
27291828	573	582	Donepezil	Chemical	MESH:D000077265
27291828	597	617	acetylcholinesterase	Gene	11423
27291828	619	623	AChE	Gene	11423
27291828	686	705	cognitive disorders	Disease	MESH:D003072
27291828	756	765	donepezil	Chemical	MESH:D000077265
27291828	784	793	histamine	Chemical	MESH:D006632
27291828	880	887	ABT-239	Chemical	MESH:C496397
27291828	892	901	donepezil	Chemical	MESH:D000077265
27291828	975	1006	glycogen synthase kinase 3 beta	Gene	56637
27291828	1008	1017	GSK-3beta	Gene	56637
27291828	1049	1058	histamine	Chemical	MESH:D006632
27291828	1068	1072	mice	Species	10090
27291828	1101	1108	ABT-239	Chemical	MESH:C496397
27291828	1112	1121	donepezil	Chemical	MESH:D000077265
27291828	1237	1260	histidine decarboxylase	Gene	15186
27291828	1272	1275	HDC	Gene	15186
27291828	1365	1368	HDC	Gene	15186
27291828	1392	1415	a-fluoromethylhistidine	Chemical	-
27291828	1417	1424	a-FMHis	Chemical	-
27291828	1427	1436	histamine	Chemical	MESH:D006632
27291828	1447	1451	mice	Species	10090
27291828	1489	1496	ABT-239	Chemical	MESH:C496397
27291828	1500	1509	donepezil	Chemical	MESH:D000077265
27291828	1540	1549	GSK-3beta	Gene	56637
27291828	1628	1637	histamine	Chemical	MESH:D006632
27291828	1647	1651	mice	Species	10090
27291828	1703	1711	LY294002	Chemical	MESH:C085911
27291828	1724	1733	GSK-3beta	Gene	56637
27291828	1810	1814	mice	Species	10090
27291828	1847	1856	donepezil	Chemical	MESH:D000077265
27291828	1861	1868	ABT-239	Chemical	MESH:C496397
27291828	2007	2010	AKT	Gene	11651
27291828	2011	2020	GSK-3beta	Gene	56637
27291828	2105	2114	histamine	Chemical	MESH:D006632
27291828	Association	MESH:D000077265	MESH:D006632
27291828	Negative_Correlation	MESH:D000077265	MESH:D003072
27291828	Negative_Correlation	MESH:C085911	56637
27291828	Negative_Correlation	MESH:C496397	99296
27291828	Association	MESH:D006632	56637
27291828	Positive_Correlation	MESH:D000077265	56637
27291828	Association	MESH:C496397	MESH:D006632
27291828	Negative_Correlation	MESH:D000077265	11423
27291828	Positive_Correlation	MESH:C496397	56637
27291828	Association	MESH:D006632	11651
27291828	Association	11651	56637

